Editorial: therapeutic drug monitoring for anti-TNF agents-has it all been said?

被引:1
|
作者
Domenech, E. [1 ,2 ]
Canete, F. [1 ]
Manosa, M. [1 ,2 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Gastroenterol & Hepatol Dept, IBD Unit, Barcelona, Spain
[2] CIBEREHD, Barcelona, Spain
关键词
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; INFLIXIMAB; COMBINATION; ADALIMUMAB; INDUCTION; TRIAL;
D O I
10.1111/apt.14350
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1113 / 1114
页数:2
相关论文
共 50 条
  • [11] A UK NATIONAL SURVEY OF THERAPEUTIC DRUG MONITORING WITH ANTI-TNF MEDICATIONS IN IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav
    Kontopantelis, Evan
    Hayee, Bu
    Limdi, Jimmy
    GUT, 2019, 68 : A86 - A87
  • [12] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [13] A UK National Survey of Therapeutic Drug Monitoring With Anti-TNF Medications in IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav B.
    Kontopantelis, Evangelos
    Hayee, Bu
    Limdi, Jimmy K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S443 - S443
  • [14] Immunogenicity of anti-TNF antibodies. Has the veil been lifted?
    Van Assche, Gert
    GUT, 2011, 60 (03) : 285 - 286
  • [15] Therapeutic drug monitoring of anti-TNFα drugs in a UK tertiary IBD unit
    Barrow, V.
    Innes, A.
    Thompson, N.
    Mansfield, J.
    Speight, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S416 - S417
  • [16] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [17] Proactive therapeutic drug monitoring of anti-TNF agents is associated with higher mucosal healing rates in Crohn's disease
    Brinar, M.
    Sabic, M.
    Turk, N.
    Grgic, D.
    Domislovic, V.
    Cavka, S. Cukovic
    Kozmar, A.
    Krznaric, Z.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S506 - S506
  • [18] Editorial: proactive anti-TNF drug monitoring in IBD-Ready for prime time?
    Roblin, Xavier
    Nancey, Stephane
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1453 - 1454
  • [19] Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
    Samaan, Mark A.
    Arkir, Zehra
    Ahmad, Tariq
    Irving, Peter M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (12) : 1271 - 1279
  • [20] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD? Authors' reply
    Roblin, Xavier
    Paul, Stephane
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1051 - 1051